Role of the Sympathetic Nervous System in Stress-Mediated Cardiovascular Disease

Current Hypertension Reports

Volumn 17, Issue 10, 2015, Pages

  Hering, Dagmara ^a   Lachowska, Kamila ^b   Schlaich, Markus ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Acute emotional stress; Cardiovascular disease; Cardiovascular risk; Depression; Hypertension; Interventional therapy; Mechanisms; Mental stress; Mortality; Non pharmacological approach; Sympathetic nervous system activity

Indexed keywords

ACUTE STRESS; ADRENERGIC SYSTEM; AUTONOMIC NERVOUS SYSTEM; BEHAVIOR THERAPY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHRONIC STRESS; DISEASE ASSOCIATION; EMOTIONAL STRESS; HUMAN; HYPERTENSION; MENTAL STRESS; NEUROMODULATION; NONHUMAN; OUTCOME ASSESSMENT; PANIC; PHYSICAL STRESS; REVIEW; SOCIAL PSYCHOLOGY; STRESS; ANIMAL; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGICAL STRESS; RISK FACTOR;

ANIMALS; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; HUMANS; RISK FACTORS; STRESS, PHYSIOLOGICAL; STRESS, PSYCHOLOGICAL; SYMPATHETIC NERVOUS SYSTEM;

EID: 84940513906     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-015-0594-5     Document Type: Review

References (62)

1. Rozanski A, Blumenthal JA, Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation. 1999;99(16):2192–217. Highly cited paper reviewing the contribution of numerous psychological factors to cardiovascular disease, the involvement of potential mechanisms and therapeutic approaches.
2. Albert CM, Chae CU, Rexrode KM, Manson JE, Kawachi I. Phobic anxiety and risk of coronary heart disease and sudden cardiac death among women. Circulation. 2005;111(4):480–7. doi:10.1161/01.Cir.0000153813.64165.5d.
3. Pan A, Sun Q, Okereke OI, Rexrode KM, Hu FB. Depression and risk of stroke morbidity and mortality a meta-analysis and systematic review. JAMA. 2011;306(11):1241–9. doi:10.1001/jama.2011.1282.
4. Dong JY, Zhang YH, Tong J, Qin LQ. Depression and risk of stroke a meta-analysis of prospective studies. Stroke. 2012;43(1):32–7. doi:10.1161/Strokeaha.111.630871.
5. Henderson KM, Clark CJ, Lewis TT, Aggarwal NT, Beck T, Guo H, et al. Psychosocial distress and stroke risk in older adults. Stroke. 2013;44(2):367–72. doi:10.1161/STROKEAHA.112.679159.
6. Jackson CA, Mishra GD. Depression and risk of stroke in midaged women: a prospective longitudinal study. Stroke. 2013;44(6):1555–60. doi:10.1161/STROKEAHA.113.001147.
7. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Heart disease and stroke statistics—2015 update: a report from the American Heart Association. Circulation. 2015;131(4):e29–322. doi:10.1161/CIR.0000000000000152.
8. Task Force M, Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013;34(38):2949–3003. doi:10.1093/eurheartj/eht296.
9. Esler M. Heart and mind: psychogenic cardiovascular disease. J Hypertens. 2009;27(4):692–5. doi:10.1097/HJH.0b013e328324f72b.
10. Buckley T, McKinley S, Tofler G, Bartrop R. Cardiovascular risk in early bereavement: a literature review and proposed mechanisms. Int J Nurs Stud. 2010;47(2):229–38. doi:10.1016/j.ijnurstu.2009.06.010.
11. Mostofsky E, Sherwood JB, Mittleman MA, Maclure M, Tofler GH, Muller JE. Response to letter regarding article, “Risk of acute myocardial infarction after the death of a significant person in one’s life: the determinants of myocardial infarction onset study”. Circulation. 2012;126(3):E37-E. doi:10.1161/Circulationaha.112.114470.
12. Leor J, Poole WK, Kloner RA. Sudden cardiac death triggered by an earthquake. N Engl J Med. 1996;334(7):413–9. doi:10.1056/NEJM199602153340701. First study demonstrating the direct association between environmental disasters such as earthquake and sudden cardiac death.
13. Sato H, Tateishi H, T. U. Takotsubo-type cardiomyopathy due to multivessel spasm. In: Kodama K, Haze K, Hon M, eds. Clinical Aspect of Myocardial Injury: From Ischemia to Heart Failure. Tokyo, Japan: Kagakuhyouronsha; 1990: 56–64. 1990. First description of Takotsubo cardiomyopathy.
14. Watanabe H, Kodama M, Okura Y, Aizawa Y, Tanabe N, Chinushi M, et al. Impact of earthquakes on Takotsubo cardiomyopathy. JAMA. 2005;294(3):305–7. doi:10.1001/jama.294.3.305.
15. Fijalkowski M, Fijalkowska M, Nowak R, Rynkiewicz A. Takotsubo cardiomyopathy in a male during a Euro 2012 football match. Clin Res Cardiol. 2013;102(4):319–21. doi:10.1007/s00392-013-0536-7.
16. Wittstein IS, Thiemann DR, Lima JA, Baughman KL, Schulman SP, Gerstenblith G, et al. Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med. 2005;352(6):539–48. doi:10.1056/NEJMoa043046. First study demonstrating that Takotsubo-stress induced cardiomyopathy is associated with increased plasma neurohumoral variables.
17. Sverrisdottir YB, Schultz T, Omerovic E, Elam M. Sympathetic nerve activity in stress-induced cardiomyopathy. Clin Auton Res. 2012;22(6):259–64. doi:10.1007/s10286-012-0162-x.
18. Vaccaro A, Despas F, Delmas C, Lairez O, Lambert E, Lambert G, et al. Direct evidences for sympathetic hyperactivity and baroreflex impairment in Tako Tsubo cardiopathy. PLoS One. 2014;9(3), e93278. doi:10.1371/journal.pone.0093278.
19. Wilbert-Lampen U, Leistner D, Greven S, Pohl T, Sper S, Volker C, et al. Cardiovascular events during World Cup soccer. N Engl J Med. 2008;358(5):475–83. doi:10.1056/NEJMoa0707427. Study demonstrating the association between emotional stress and acute cardiovascular events.
20. Esler M, Jennings G, Lambert G. Measurement of overall and cardiac norepinephrine release into plasma during cognitive challenge. Psychoneuroendocrinology. 1989;14(6):477–81. First study demonstrating increased cardiac noradrenaline spillover in response to mental stress test in essential hypertension.
21. Deanfield JE, Shea M, Kensett M, Horlock P, Wilson RA, de Landsheere CM, et al. Silent myocardial ischaemia due to mental stress. Lancet. 1984;2(8410):1001–5. First study demonstrating reduced myocardial blood flow during mental stress test in patients with coronary artery disease.
22. Rumantir MS, Jennings GL, Lambert GW, Kaye DM, Seals DR, Esler MD. The 'adrenaline hypothesis' of hypertension revisited: evidence for adrenaline release from the heart of patients with essential hypertension. J Hypertens. 2000;18(6):717–23. First study indicating augmented adrenaline release from cardiac sympathetic nerves and the relevant contribution of adrenaline co-transmission in triggering noradrenaline release in essential hypertension development.
23. Muller JE, Kaufmann PG, Luepker RV, Weisfeldt ML, Deedwania PC, Willerson JT. Mechanisms precipitating acute cardiac events: review and recommendations of an NHLBI workshop. National Heart, Lung, and Blood Institute. Mechanisms precipitating acute cardiac events participants. Circulation. 1997;96(9):3233–9.
24. Everson-Rose SA, Roetker NS, Lutsey PL, Kershaw KN, Longstreth Jr WT, Sacco RL, et al. Chronic stress, depressive symptoms, anger, hostility, and risk of stroke and transient ischemic attack in the multi-ethnic study of atherosclerosis. Stroke. 2014;45(8):2318–23. doi:10.1161/STROKEAHA.114.004815.
25. Huo Y, Li JP, Qin XH, Huang YN, Wang XB, Gottesman RF, et al. Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China the CSPPT randomized clinical trial. JAMA. 2015;313(13):1325–35. doi:10.1001/jama.2015.2274.
26. Wilkinson DJ, Thompson JM, Lambert GW, Jennings GL, Schwarz RG, Jefferys D, et al. Sympathetic activity in patients with panic disorder at rest, under laboratory mental stress, and during panic attacks. Arch Gen Psychiatry. 1998;55(6):511–20. First study demonstrating sympathetic activity in patients with panic disorder.
27. Mansour VM, Wilkinson DJ, Jennings GL, Schwarz RG, Thompson JM, Esler MD. Panic disorder: coronary spasm as a basis for cardiac risk? Med J Aust. 1998;168(8):390–2.
28. Airaksinen KE. Autonomic mechanisms and sudden death after abrupt coronary occlusion. Ann Med. 1999;31(4):240–5. doi:10.3109/07853899908995886.
29. Ciecwierz D, Hering D, Somers VK, Wdowczyk-Szulc J, Kara T, Skarzynski P, et al. Sympathetic neural responses to coronary occlusion during balloon angioplasty. J Hypertens. 2007;25(8):1650–4. doi:10.1097/HJH.0b013e3281cd40e1. First study demonstrating the acute effect of coronary balloon angioplasty on muscle sympathetic nerve activity in patients with coronary artery disease.
30. Musselman DL, Evans DL, Nemeroff CB. The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch Gen Psychiatry. 1998;55(7):580–92.
31. Glassman AH, Shapiro PA. Depression and the course of coronary artery disease. Am J Psychiatry. 1998;155(1):4–11.
32. Rosengren A, Hawken S, Ounpuu S, Sliwa K, Zubaid M, Almahmeed WA, et al. Association of psychosocial risk factors with risk of acute myocardial infarction in 11119 cases and 13648 controls from 52 countries (the INTERHEART study): case–control study. Lancet. 2004;364(9438):953–62. doi:10.1016/S0140-6736(04)17019-0. Most relevant clinical trial demonstrating the relationship between psychosocial factors and myocardial infarction.
33. Penninx BW, Beekman AT, Honig A, Deeg DJ, Schoevers RA, van Eijk JT, et al. Depression and cardiac mortality: results from a community-based longitudinal study. Arch Gen Psychiatry. 2001;58(3):221–7.
34. Russ TC, Stamatakis E, Hamer M, Starr JM, Kivimaki M, Batty GD. Association between psychological distress and mortality: individual participant pooled analysis of 10 prospective cohort studies. Brit Med J. 2012;345. doi:10.1136/Bmj.E4933.
35. Barton DA, Dawood T, Lambert EA, Esler MD, Haikerwal D, Brenchley C, et al. Sympathetic activity in major depressive disorder: identifying those at increased cardiac risk? J Hypertens. 2007;25(10):2117–24. doi:10.1097/HJH.0b013e32829baae7. First study demonstrating increased levels of cardiac noradrenaline spillover in major depressive disorder patients.
36. Steptoe A, Willemsen G. The influence of low job control on ambulatory blood pressure and perceived stress over the working day in men and women from the Whitehall II cohort. J Hypertens. 2004;22(5):915–20.
37. Timio M, Saronio P, Venanzi S, Gentili S, Verdura C, Timio F. Blood pressure in nuns in a secluded order: a 30-year follow-up. Miner Electrolyte Metab. 1999;25(1–2):73–9. First long-term follow-up study indicating the potential impact of stressfull environments on hypertension development and the importance of sympathetic activation on cardiovascular outcomes.
38. Narkiewicz K, Phillips BG, Kato M, Hering D, Bieniaszewski L, Somers VK. Gender-selective interaction between aging, blood pressure, and sympathetic nerve activity. Hypertension. 2005;45(4):522–5. doi:10.1161/01.HYP.0000160318.46725.46. First study demonstrating the impact of age and gender on sympathetic activation in healthy subjects.
39. Crump C, Winkleby MA, Sundquist K, Sundquist J. Comorbidities and mortality in persons with schizophrenia: a Swedish National Cohort Study. Am J Psychiatry. 2013;170(3):324–33. doi:10.1176/appi.ajp.2012.12050599.
40. Hennekens CH, Hennekens AR, Hollar D, Casey DE. Schizophrenia and increased risks of cardiovascular disease. Am Heart J. 2005;150(6):1115–21. doi:10.1016/j.ahj.2005.02.007.
41. Davidson M. Risk of cardiovascular disease and sudden death in schizophrenia. J Clin Psychiatry. 2002;63 Suppl 9:5–11.
42. Ray WA, Chung CP, Murray KT, Hall K, Stein CM. Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med. 2009;360(3):225–35. doi:10.1056/Nejmoa0806994. First study comparing the effects of typical and atypical antipsychotic drugs on sudden cardiac death.
43. Newcomer JW, Haupt DW. The metabolic effects of antipsychotic medications. Can J Psychiatr. 2006;51(8):480–91.
44. Krum H, Schlaich MP, Sobotka PA, Bohm M, Mahfoud F, Rocha-Singh K, et al. Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study. Lancet. 2014;383(9917):622–9. doi:10.1016/S0140-6736(13)62192-3. First study demonstrating sustained blood pressure reduction out to 3 years following renal denervation in patients with resistant hypertension.
45. Esler MD, Bohm M, Sievert H, Rump CL, Schmieder RE, Krum H, et al. Catheter-based renal denervation for treatment of patients with treatment-resistant hypertension: 36 month results from the SYMPLICITY HTN-2 randomized clinical trial. Eur Heart J. 2014;35(26):1752–9. doi:10.1093/eurheartj/ehu209. First randomized-controlled study demonstrating the long-term effect of renal denervation on sustained blood pressure reduction in patients with resistant hypertension.
46. Schneider RH, Grim CE, Rainforth MV, Kotchen T, Nidich SI, Gaylord-King C, et al. Stress reduction in the secondary prevention of cardiovascular disease: randomized, controlled trial of transcendental meditation and health education in Blacks. Circ Cardiovasc Qual Outcomes. 2012;5(6):750–8. doi:10.1161/CIRCOUTCOMES.112.967406. First study demonstrating the favourable effect of transcendental meditation in reducing cardiovascular outcomes.
47. Parati G, Izzo Jr JL, Gavish B. Respiration and blood pressure. In: Izzo Jr J, Sica D, Black HR, editors. Hypertension primer. Baltimore: Lippincott, Williams, and Wilkins; 2008. p. 136–8. Chapter 143.
48. Spicuzza L, Gabutti A, Porta C, Montano N, Bernardi L. Yoga and chemoreflex response to hypoxia and hypercapnia. Lancet. 2000;356(9240):1495–6. doi:10.1016/S0140-6736(00)02881-6. First study assessing the impact of long-term yoga on chemoreflex sensitivity.
49. Oneda B, Ortega KC, Gusmao JL, Araujo TG, Mion Jr D. Sympathetic nerve activity is decreased during device-guided slow breathing. Hypertens Res. 2010;33(7):708–12. doi:10.1038/hr.2010.74.
50. Hering D, Kucharska W, Kara T, Somers VK, Parati G, Narkiewicz K. Effects of acute and long-term slow breathing exercise on muscle sympathetic nerve activity in untreated male patients with hypertension. J Hypertens. 2013. doi:10.1097/HJH.0b013e32835eb2cf. First study assessing the long-term slow breathing effect on sympathetic activity in untreated essential hypertension.
51. Stults-Kolehmainen MA, Sinha R. The effects of stress on physical activity and exercise. Sports Med. 2014;44(1):81–121. doi:10.1007/s40279-013-0090-5.
52. Craft LL, Perna FM. The benefits of exercise for the clinically depressed. Prim Care Companion J Clin Psychiatry. 2004;6(3):104–11.
53. Blumenthal JA, Babyak MA, Moore KA, Craighead E, Herman S, Khatri P, et al. Effects of exercise training on older patients with major depression. Arch Intern Med. 1999;159(19):2349–56. doi:10.1001/archinte.159.19.2349.
54. DiLorenzo TM, Bargman EP, Stucky-Ropp R, Brassington GS, Frensch PA, LaFontaine T. Long-term effects of aerobic exercise on psychological outcomes. Prev Med. 1999;28(1):75–85. doi:10.1006/pmed.1998.0385.
55. Lawlor DA, Hopker SW. The effectiveness of exercise as an intervention in the management of depression: systematic review and meta-regression analysis of randomised controlled trials. Br Med J. 2001;322(7289):763–7. doi:10.1136/bmj.322.7289.763.
56. Allen EV, Adson AW. Physiologic effects of extensive sympathectomy for essential hypertension—further observations. Ann Intern Med. 1938;11(12):2151–71.
57. Hoobler SW, Manning JT, Paine WG, Mc CS, Helcher PO, Renfert Jr H, et al. The effects of splanchnicectomy on the blood pressure in hypertension; a controlled study. Circulation. 1951;4(2):173–83.
58. Campese VM, Kogosov E, Koss M. Renal afferent denervation prevents the progression of renal disease in the renal ablation model of chronic renal failure in the rat. Am J Kidney Dis. 1995;26(5):861–5.
59. Campese VM, Kogosov E. Renal afferent denervation prevents hypertension in rats with chronic renal failure. Hypertension. 1995;25(4 Pt 2):878–82. First study demonstrating the contribution of afferent renal nerves from the failing kidney to the brain stem resulting in blood pressure elevation and sympathetic activation.
60. Ferrier C, Jennings GL, Eisenhofer G, Lambert G, Cox HS, Kalff V, et al. Evidence for increased noradrenaline release from subcortical brain regions in essential hypertension. J Hypertens. 1993;11(11):1217–27. First study demonstrating increased brain noradrenaline turnover in the pathophysiology of human essential hypertension.
61. Lambert GW, Hering D, Esler MD, Marusic P, Lambert EA, Tanamas SK, et al. Health-related quality of life after renal denervation in patients with treatment-resistant hypertension. Hypertension. 2012;60(6):1479–84. doi:10.1161/HYPERTENSIONAHA.112.200865. First study demonstrating an improvement in several aspects of quality of life in patients with resistant hypertension following renal denervation.
62. Lenski D, Kindermann I, Lenski M, Ukena C, Bunz M, Mahfoud F, et al. Anxiety, depression, quality of life and stress in patients with resistant hypertension before and after catheter-based renal sympathetic denervation. Eurointervention. 2013;9(6):700–8. doi:10.4244/Eijv916a114.